A2AR antagonists can be of help for treatment of morphine use disorder, but like in cocaine use disorder treatment, the design of interface interfering peptides and/or hetero-bivalent compounds with D2R agonist and A2AR antagonist pharmacophors may be necessary to develop (Borroto-Escuela et al., 2018a). This evidence concerns the gene ADORA2A and cocaine use disorder.